Miracle drug innovations — such as those that sparked the meteoric rise of Wegovy and Zepbound — could come every couple of ...
SAN FRANCISCO, CA / ACCESS Newswire / January 21, 2025 / Gala introduces a groundbreaking digital health platform that ...
Zepbound's huge success is largely why investors are bullish on the business, and why it looks unstoppable. And as the company works on oral drugs and other weight loss treatments, it could unlock ...
A Bucks County woman is speaking out after her insurance company decided to no longer cover weight loss drugs.
This year, revolutionary anti-obesity drugs Wegovy and Ozempic (manufactured by Danish drugmaker Novo Nordisk), and Eli Lilly ...
In the ongoing quest to expand semaglutide’s clinical pedigree and cement the GLP-1's market position, Novo Nordisk is ...
Metabolic medicines dominated life sciences headlines in 2024, a trend expected to continue into the new year. Other things ...
The stupendous success of Mounjaro and Zepbound has made Lilly the largest drugmaker with a market cap of more than $734 billion. Lilly’s stock has gone up by 479% in the past five years ...
In the company's third-quarter report in October, Lilly reported sales of both Mounjaro and Zepbound that missed ... our mission of empowering investor success. We provide a platform for our ...